This review highlights the critical role of mitochondrial dysfunction, including genetic mutations and metabolic defects, in the development and progression of heart failure and cardiomyopathies.
Answers are grounded in this paper and cite their sources.
May guide mitochondrial-targeted interventions in cardiomyopathies; leaves open clinical translation pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
José Marı́n-Garcı́a (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: